Il 6-7 Giugno si terrà a Roma, presso il Circolo Ufficiali delle Forze Armate d’Italia (Via XX Settembre 2), il 9th LIPIDCLUB & Therapeutic Apheresis 2014 - Interdisciplinary Educational Forum.
Il corso, dal titolo"Updating in Apheresis and Atherosclerosis Research", è valido per l'accreditamento ECM.
L'evento è promosso da Aegerion, Braun, Fresenius Medical Care, Kaneka Pharma Europe, Difass International, Emac ed Haemoclub International a sostegno del LipidClub, dello Studio Multicentrico Italiano LDL-aferesi e del MIGHTY MEDIC - Multidisciplinary International Group for Hemapheresis TherapY and MEtabolic DIsturbances Contrast.
PROGRAMMA:
Venerdì 6 Giugno
09.15 Welcome remarks
Brigadier General Rinaldo Rinaldin - Direttore del Circolo Ufficiali delle Forze Armate d’Italia
Professor Eugenio Gaudio - Preside della Facoltà di Medicina e Farmacia - Università “Sapienza”
Savino Vigliaroli Presidente A.N.I.F. Associazione Nazionale Ipercolesterolemia Familiare
Chairs: U. Julius, C. Stefanutti, P. Moriarty
09.30 The present treatment of elevated Lp(a) and CVD prevention: lipid-apheresis
Patrick Moriarty
09.50 Effect of lipoprotein apheresis on cardiovascular events in patients with elevated Lipoprotein (a) levels
Ulrich Julius
10.10 Familial Hypercholesterolaemia: genetic testing and problems related to the development of a target therapy
Clara Balsano
10.30 Treatment of HoFH by Lomitapide. Long-term extension study: preliminary outcome
Claudia Stefanutti
10.50 Discussion
Coffee break
11.00 Hyperlipidaemia in children
Ornella Guardamagna
11.20 Natural history of FH in Greece: epidemiological findings (clinical/genetic) in 34 Homozygous FH children, teenagers and adults
Euridiki Drogari
11.40 Pitavastatin’s low potential for CYP3A4-mediated drug-to-drug interactions makes it an option for sensitive patients.
Clinical experience from the NK-104-4.02EU Clinical Trial on HeFH Children
Claudia Morozzi, Serafina Di Giacomo
12.10 Treatment of severe Hypertriglyceridaemia and Hyperchylomicronaemia
Wolfang Ries
12.30 To promote health through the European research infrastructures
Elena Bravo
12.50 Discussion
13.15 Closing remarks
Sabato 7 Giugno
Chairs: M. Harada Shiba, B. Jaeger, C. Stefanutti
09.00 FH genetic diagnosis by targeted next generation sequencing
Stefano Romeo
09.20 Potential of the H.E.L.P. apheresis in the treatment of ischemic stroke and some other peculiar indications
Beate Jaeger
09.40 Lipoprotein apheresis in UK: current state
Handrean Soran
10.00 Management of pregnancy and delivery in 4 Homozygous FH with LDL apheresis
Mariko Harada Shiba
10.20 Management of pregnancy and delivery for other indications of therapeutic apheresis
Giuseppina Perrone
10.40 Imaging of Cardiovascular Disease. Current status and novel techniques
Gianfranco Gualdi
11.00 Discussion
Coffee break
The MIGHTY MEDIC Working Group General Assembly
Multidisciplinary International Group for Hemapheresis TherapY and MEtabolic DIsturbances Contrast
Chairs: M. Harada Shiba, U. Julius, C. Stefanutti
11.30 1st International survey results - Upcoming scientific activity and research projects
Claudia Stefanutti, Giovanna D’Alessandri
MIGHTY MEDIC MEMBERS
11.50 Morphometric analysis of circulating blood cells in atherosclerosisrelated conditions
Giorgio Bianciardi
12.10 Chronic Kidney Disease as cardiovascular risk predictor. Evidence based clinical management
Fabio Mazza
12.25 Clinical Trials: the role of a Research Nurse
Orietta Macciocca
12.40 Discussion
13.00 CME Questionnaire
13.30 Closing remarks
Seguici sui Social